EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database

Zhenyu Wang, Jianan Jin iD, Guimei Wang, Guoqi Zhou, Hanliang Jiang

PLOS One · 2026

DOI: 10.1371/journal.pone.0340684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Zhenyu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary and Critical Care Medicine, Regional medical center for National Institute of Respiratory Disease, Sir Run Run Shaw Hospital, School of Med…. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Medical and Health Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Proton pump inhibitors (PPIs), known for their potent acid-suppressing effects, are widely used in various clinical settings, including treatment and prevention. Understanding their adverse effects is crucial. This study, utilizing the FDA Adverse Event Reporting System (FAERS) database, comprehensively analyzes PPI-related adverse events to guide clinical medication practices.

Methods

This study analyzed suspected adverse drug reactions (ADRs) related to specific PPI drugs using data from the FAERS database, covering Q1 2004 to Q4 2024. Multiple statistical methods, including ROR, PRR, IC025, and EBGM, were employed for evaluation, with ADRs defined according to System Organ Class (SOC) and Preferred Term (PT). A comparative analysis was conducted to assess potential differences in ADR profiles among different PPI drugs.

Results

This study analyzed 176,680 cases of PPI-related adverse events, with a total of 632,468 adverse reaction reports recorded when PPIs were designated as the primary suspected drug (PS). PPIs showed significantly elevated risks in the renal/urinary and gastrointestinal systems, with other common adverse reactions including hypomagnesemia, hypocalcemia, and renal anemia. Most adverse reactions occurred either within the first 0–30 days of use or after prolonged exposure (>6 months), and elderly patients (≥65 years) were disproportionately affected.

Conclusions

For high-risk populations using PPIs long-term (such as elderly patients or those with pre-existing renal impairment), continuous monitoring is essential to mitigate potential complications. Unnecessary use should be strictly avoided, and long-term medication should be minimized to ensure safety and appropriateness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsUnited StatesHumansUnited States Food and Drug AdministrationDatabases, FactualFemale

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Pulmonary and Critical Care Medicine, Regional medical center for National Institute of Respiratory Disease, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, P. R. China.
  • School of Medicine, Shaoxing university, Shaoxing, Zhejiang, People's Republic of China.
  • Graduate School, Zhejiang Chinese Medical University, People's Republic of China.
  • Pulmonary Disease Department, Zunyi of Traditional Hospital Chinese Medicine, Zunyi, Guizhou, People's Republic of China.

ORCID-Profile: Jianan Jin

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Medical and Health Science and Technology Project

Zitieren

APA

Wang, Z., Jin, J., Wang, G., Zhou, G., & Jiang, H. (2026). Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database. PLOS One. https://doi.org/10.1371/journal.pone.0340684

Vancouver

Wang Z, Jin J, Wang G, Zhou G, Jiang H. Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database. PLOS One. 2026. doi:10.1371/journal.pone.0340684

BibTeX
@article{Wang2026,
  author = {Wang, Zhenyu and Jin, Jianan and Wang, Guimei and Zhou, Guoqi and Jiang, Hanliang},
  title = {Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0340684}
}
Kostenlos starten →